Effect of Surgery on Prognosis of Laryngeal Cancer Patients and Its Influencing Factors: A Retrospective Study Based on Seer Database
DOI:
https://doi.org/10.62382/jcbt.v2i2.40Keywords:
Overall survival, Laryngeal cancer-specific survival, Laryngeal cancer, SEER, PrognosisAbstract
Background: Currently, the primary treatment modality for laryngeal cancer (LC) is surgery. However, there is almost no evidence on the effectiveness of surgical resection in the prognosis of laryngeal cancer patients.. Furthermore, the prognostic factors influencing outcomes in patients undergoing surgery for laryngeal cancer remain largely unexplored and poorly understood.
Methods: In this study, 59,873 patients with laryngeal tumors from 2000 to 2021 in the Surveillance, Epidemiology, and End Results (SEER) database were analyzed retrospectively. First, we applied propensity score matching (PSM) to construct a balanced cohort with and without surgery by 1:1 pairing with 0.2 standard deviation. After that, Kaplan-Meier analysis and multivariate Cox regression analysis were conducted to assess the therapeutic effect of surgery on patients and we used overall survival (OS) and laryngeal cancer-specific survival (LCSS) to measure it. The two groups were compared by constructing Fine-Gray competitive risk model. The nomogram prediction model of OS and LCSS in patients undergoing LC surgery was established by R software. Finally, the feasibility of the model was verified by calibration curve and consistency index (C-index).
Results: A total of 12,283 eligible patients were screened out, and 6,446 (52.4%) patients among it have received surgery. 7393 patients were successfully matched by PSM, and there was roughly a balance between the groups. In the matched data set, multivariate Cox analysis shows that surgery can reduce the risk of OS by 35.9%(HR=0.641, 95%CI 0.606 to 0.677) and the risk of LCSS by 41.5%(HR=0.585, 95%CI 0.533 to 0.641). The competitive risk model also shows that surgery can reduce the risk of patients. In addition, the nomogram model indicates that the surgical patients with radiotherapy can benefit more from surgery, while the patients with chemotherapy may be negatively affected.Finally, the 1-year, 5-year and 10-year survival rates of patients are intuitively visualized.
Conclusion: This study provides evidence that surgery can improve the prognosis of patients with laryngeal cancer, especially the subgroup of patients with glottic tumors and radiotherapy.
Downloads
References
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians. 2024, 74(3), 229-263. DOI: 10.3322/caac.21834
Che WQ, Li YJ, Tsang CK, Wang YJ, Chen Z, et al. How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology. Military Medical Research. 2023, 10(1), 50. DOI: 10.1186/s40779-023-00488-2
Karatzanis AD, Psychogios G, Waldfahrer F, Kapsreiter M, Zenk J, et al. Management of locally advanced laryngeal cancer. Journal of Otolaryngology - Head & Neck Surgery. 2014, 43(1), 4. DOI: 10.1186/1916-0216-43-4
Liberale C, Soloperto D, Marchioni A, Monzani D, Sacchetto L. Updates on Larynx Cancer: Risk Factors and Oncogenesis. International Journal of Molecular Sciences. 2023, 24(16), 12913. DOI: 10.3390/ijms241612913
Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. The Lancet. Oncology. 2014, 15(12), 1319-31. DOI: 10.1016/S1470-2045(14)70471-1
Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA: a Cancer Journal for Clinicians. 2017, 67(1), 31-50. DOI: 10.3322/caac.21386
Kiss B, Neagos CM, Jimborean G, Sárközi HK, Szathmary M, et al. Comorbidities and Laryngeal Cancer in Patients with Obstructive Sleep Apnea: A Review. Medicina (Kaunas). 2023, 59(11), 1959. DOI: 10.3390/medicina59111959
Megwalu UC, Sikora AG. Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngology-- Head & Neck Surgery. 2014, 140(9), 855-60. DOI: 10.1001/jamaoto.2014.1671
Huang J, Chan SC, Ko S, Lok V, Zhang L, et al. Updated disease distributions, risk factors, and trends of laryngeal cancer: a global analysis of cancer registries. International Journal of Surgery. 2024, 110(2), 810-819. DOI: 10.1097/JS9.0000000000000902
Wang JY, Zhang QW, Wen K, Wang C, Ji X, et al. Temporal trends in incidence and mortality rates of laryngeal cancer at the global, regional and national levels, 1990-2017. BMJ Open. 2021, 11(10), e050387. DOI: 10.1136/bmjopen-2021-050387
Chen AY, Halpern M. Factors predictive of survival in advanced laryngeal cancer. Archives of Otolaryngology--Head & Neck Surgery. 2007, 133(12), 1270-6. DOI: 10.1001/archotol.133.12.1270
Davis GE, Schwartz SR, Veenstra DL,Yueh B. Cost comparison of surgery vs organ preservation for laryngeal cancer. Archives of Otolaryngology--Head & Neck Surgery. 2005, 131(1), 21-6. DOI: 10.1001/archotol.131.1.21
Sessions DG, Lenox J, Spector GJ, Newland D, Simpson J, et al. Management of T3N0M0 glottic carcinoma: therapeutic outcomes. The Laryngoscope. 2002, 112(7 Pt 1), 1281-8. DOI: 10.1097/00005537-200207000-00026
Afify AY, Ashry MH, Sadeq MA, Elsaid M. Causes of death after laryngeal cancer diagnosis: A US population-based study. European Archives of Oto-Rhino-Laryngology. 2023, 280(4), 1855-1864. DOI: 10.1007/s00405-022-07730-y
Li MM, Zhao S, Eskander A, Rygalski C, Brock G, et al. Stage Migration and Survival Trends in Laryngeal Cancer. Annals of Surgical Oncology. 2021, 28(12), 7300-7309. DOI: 10.1245/s10434-021-10318-1
Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A. Current trends in initial management of laryngeal cancer: the declining use of open surgery. European Archives of Oto-Rhino-Laryngology. 2009, 266(9), 1333-52. DOI: 10.1007/s00405-009-1028-2
Liu Y, Yang HY, Li T, Zhang N. Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment. Frontiers in Immunology. 2024, 15, 1460282. DOI: 10.3389/fimmu.2024.1460282
Tagliabue M, Maffini F, Fumagalli C, Gandini S, Lepanto D, et al. A role for the immune system in advanced laryngeal cancer. Scientific Reports. 2020, 10(1), 18327. DOI: 10.1038/s41598-020-73747-0
Gao W, Guo HN, Niu M, Zheng XW, Zhang YL, et al. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Molecular Cancer. 2020, 19(1), 166. DOI: 10.1186/s12943-020-01279-2
Wang YY, Zhang J, Yang YC, Liu ZF, Sun SJ, et al. Circular RNAs in human diseases. MedComm (2020). 2024, 5(9), e699. DOI: 10.1002/mco2.699
Pan YF, Hong YM, Liang ZY, Zhuang W. Survival analysis of distant metastasis of laryngeal carcinoma: analysis based on SEER database. European Archives of Oto-Rhino-Laryngology. 2019, 276(1), 193-201. DOI: 10.1007/s00405-018-5244-5
Marioni G, Marchese-Ragona R, Cartei G, Marchese F, Staffieri A. Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treatment Reviews. 2006, 32(7), 504-15. DOI: 10.1016/j.ctrv.2006.07.002
Dubal PM, Svider PF, Kam D, Dutta R, Baredes S, et al. Laryngeal Verrucous Carcinoma: A Population-Based Analysis. Otolaryngology--Head and Neck Surgery. 2015, 153(5), 799-805. DOI: 10.1177/0194599815591981
Hrelec C. Management of Laryngeal Dysplasia and Early Invasive Cancer. Current Treatment Options in Oncology. 2021, 22(10), 90. DOI: 10.1007/s11864-021-00881-w
Baird BJ, Sung CK, Beadle BM, Divi V. Treatment of early-stage laryngeal cancer: A comparison of treatment options. Oral Oncology. 2018, 87, 8-16. DOI: 10.1016/j.oraloncology.2018.09.012
Bonomi MR, Blakaj A, Blakaj D. Organ preservation for advanced larynx cancer: A review of chemotherapy and radiation combination strategies. Oral Oncology. 2018, 86, 301-306. DOI: 10.1016/j.oraloncology.2018.10.004
Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The New England Journal of Medicine. 1991, 324(24), 1685-90. DOI: 10.1056/NEJM199106133242402
Spector ME, Rosko AJ, Swiecicki PL, Chad Brenner J, Birkeland AC. From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer. Oral Oncology. 2018, 86, 200-205. DOI: 10.1016/j.oraloncology.2018.09.026
Fong PY, Tan SH, Lim DWT, Tan EH, Ng QS, et al. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC). PLoS One. 2019, 14(11), e0224665. DOI: 10.1371/journal.pone.0224665
Denaro N, Russi EG, Lefebvre JL, Merlano MC. A systematic review of current and emerging approaches in the field of larynx preservation. Radiotherapy and Oncology. 2014, 110(1), 16-24. DOI: 10.1016/j.radonc.2013.08.016
Patel TD, Echanique KA, Yip C, Hsueh WD, Baredes S, et al. Supraglottic Squamous Cell Carcinoma: A Population-Based Study of 22,675 Cases. The Laryngoscope. 2019, 129(8), 1822-1827. DOI: 10.1002/lary.27592
Smee RI, Meagher NS, Williams JR, Broadley K, Bridger GP. Role of radiotherapy in early glottic carcinoma. Head & Neck. 2010, 32(7), 850-9. DOI: 10.1002/hed.21262
Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. Journal of Clinical Oncology. 2001, 19(20), 4029-36. DOI: 10.1200/JCO.2001.19.20.4029
Laccourreye O, Hans S, Borzog-Grayeli A, Maulard-Durdux C, Brasnu D, et al. Complications of postoperative radiation therapy after partial laryngectomy in supraglottic cancer: A long-term evaluation. Otolaryngology--head and Neck Surgery. 2000, 122(5), 752-7. DOI: 10.1016/S0194-5998(00)70210-5
Tang T, Zhou FX, Lei H, Yu HJ, Xie CH, et al. Increased expression of telomere-related proteins correlates with resistance to radiation in human laryngeal cancer cell lines. Oncology Reports. 2009, 21(6), 1505-9. DOI: 10.3892/or_00000381
Zhu Y, Shi LY, Lei YM, Bao YH, Li ZY, et al. Radiosensitization effect of hsa-miR-138-2-3p on human laryngeal cancer stem cells. PeerJ. 2017, 5, e3233. DOI: 10.7717/peerj.3233
Poonia SK, Nicolli E. Surgical Management of Advanced Glottic Cancer. Otolaryngologic Clinics of North America. 2023, 56(2), 275-283. DOI: 10.1016/j.otc.2022.12.007
Krutz M, Acharya P, Elliott J, Zhao D, Mhawej R, et al. Tobacco Cessation Following Laryngeal Cancer Diagnosis Predicts Response to Treatment and Laryngectomy-Free Survival. Otolaryngology--Head and Neck Surgery. 2024, 170(2), 438-446. DOI: 10.1002/ohn.567
Raad RA, Holland K, Ritz EM, Tajudeen BA, Al-Khudari S, et al. A nationwide analysis of salvage surgery for laryngeal cancer in the elderly. Head & Neck. 2023, 45(11), 2915-2924. DOI: 10.1002/hed.27525
Hamilton DW, O'Hara J, Rajgor A, Selby G, Anderson M, et al. Precision medicine in laryngeal cancer: protocol of the laryngeal cancer cohort (LARCH). BMJ Open. 2023, 13(1), e067561. DOI: 10.1136/bmjopen-2022-067561
Crosetti E, Fantini M, Bertotto I, Bertolin A, Arrigoni G, et al. Current Status of Partial Laryngeal Surgery for Advanced Laryngeal Cancer: When and Why? Current Oncology Reports. 2024, 26(6), 614-624. DOI: 10.1007/s11912-024-01516-7
Starmer H, Gourin C, Lua LL, Burkhead L. Pretreatment swallowing assessment in head and neck cancer patients. The Laryngoscope. 2011, 121(6), 1208-11. DOI: 10.1002/lary.21800
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Cancer Biomoleculars and Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
